AACR Journals
Aditya Bardia, Francois-Clement Bidard, Patrick Neven; Guillermo Streich
Abstract GS3-01: GS3-01 EMERALD phase 3 trial of elacestrant versus standard of care endocrine therapy in patients with ER+/HER2- metastatic breast cancer: Updated results by duration of prior CDK4/6i in metastatic setting
TypePublicatie
Jaar2023
Volume83(5)
Pagina
DOIhttps://doi.org/10.1158/1538-7445.SABCS22-GS3-01
SpecialisatieOncologie
Artsen AZNdr. Ines Deleu
AuteursAditya Bardia, Francois-Clement Bidard, Patrick Neven; Guillermo Streich, Alberto J. Montero, Frederic Forget, Marie-Ange Mouret-Reynier, Joo Hyuk Sohn, Donatienne Taylor, Kathleen K. Harnden, Hung Khong, Judit Kocsis, Florence Dalenc, Patrick Dillon, Sunil Babu, Simon Waters, Ines Deleu, Jose Angel García-Sáenz, Emilio Bria, Marina Elena Cazzaniga, Philippe Aftimos, Javier Cortés, Giulia Tonini, Tarek Sahmoud, Nassir Habboubi, Krzysztof Grzegorzewski, Virginia Kaklamani